Toyobo Co., Ltd.
Stock Price Chart
2026/10/09 12:26 UpdatedPrice Trend
2026/10/09 12:26 UpdatedPrice & Trading Details
2026/10/09 12:26 UpdatedPRICE
TRADING
Analyst Recommendations 3 analysts
Updated 2026/10/01Earnings Calendar
Updated 2026/10/01Shareholder Composition
Updated 2026/10/01Dividend History
Updated 2026/10/04| Year | Dividend | Change |
|---|---|---|
| 2026 | ¥40 | 0.0% |
| 2025 | ¥40 | 0.0% |
| 2024 | ¥40 | 0.0% |
| 2023 | ¥40 | 0.0% |
| 2022 | ¥40 | - |
Financial Performance
2026/10/04 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥375,720M | ¥399,921M | ¥414,265M | ¥422,032M |
| Gross Profit | ¥96,126M | ¥85,006M | ¥87,998M | ¥97,055M |
| Operating Income | ¥28,430M | ¥10,063M | ¥8,995M | ¥16,653M |
| Pretax Income | ¥16,007M | ¥1,940M | ¥6,942M | ¥9,350M |
| Net Income | ¥12,865M | -¥655M | ¥2,455M | ¥2,003M |
| EPS | ¥144.75 | -¥7.37 | ¥27.87 | ¥22.73 |
| Operating Margin | 7.57% | 2.52% | 2.17% | 3.95% |
| Balance Sheet | ||||
| Total Assets | ¥517,774M | ¥588,906M | ¥606,990M | ¥617,799M |
| Total Equity | ¥194,876M | ¥189,589M | ¥197,032M | ¥195,312M |
| Total Liabilities | ¥322,898M | ¥399,317M | ¥409,958M | ¥422,487M |
| Cash | ¥27,176M | ¥60,703M | ¥33,796M | ¥28,581M |
| Interest-bearing Debt | ¥187,691M | ¥225,166M | ¥242,091M | ¥261,070M |
| Equity Ratio | 37.64% | 32.19% | 32.46% | 31.61% |
| D/E Ratio | 0.96 | 1.19 | 1.23 | 1.34 |
| Cash Flow | ||||
| Operating CF | ¥17,097M | ¥7,798M | ¥21,595M | ¥30,118M |
| Investing CF | -¥24,608M | -¥36,011M | -¥58,784M | -¥46,386M |
| Financing CF | -¥1,729M | ¥61,295M | ¥8,260M | ¥10,490M |
| Free CF | -¥12,015M | -¥31,360M | -¥35,034M | -¥15,107M |
| Efficiency | ||||
| ROE | 6.60% | -0.35% | 1.25% | 1.03% |
| ROA | 2.48% | -0.11% | 0.40% | 0.32% |
Latest IR Information
-
Notice of Simplified and Abbreviated Split through Absorption-type Company Split with a Fully Owned Subsidiary
The intermediate textile business for Middle East markets under the wholly owned subsidiary Toyobo Textile Co., Ltd. will be inherited by absorption-type split into Toyobo Co., Ltd. Schedule: Board approval on 2026/09/25, contract signing on 2026/09/28, effective date on 2027/04/01....
Read more -
Announcement regarding the transfer of fixed assets of a subsidiary in El Salvador and the recording of extraordinary gains
Sell or transfer the assets held by the El Salvador subsidiary I USA, and plan to record fixed asset disposal gains as extraordinary gains in the consolidated results for the fiscal years ending March 2027 and March 2028. The consolidated...
Read more -
Notice Regarding Suspension of Operations at the El Salvador Subsidiary
Resolved by the Board of Directors to suspend operations of consolidated subsidiary INDUSTRIAS UNIDAS, S.A. The suspension is planned for the end of November 2026. IUSA has a history of revenue in the apparel and textile manufacturing and sales business...
Read more -
FY2026 Q1 Financial Summary
Sales in Q1 grew by 13.4% year on year, with operating income up 29.0%. Segment-wise increases are observed in film, life science, environment, and functional materials, contributing to overall EBITDA growth. The outlook anticipates solid growth by segment.
Read more
Latest News (5 items)
-
Average Analyst Rating: none
Average Target Price: ¥2,150
Rating Score: 1.67 (Based on 3 analysts)
※1=Strong Buy, 5=Strong Sell
Company Information
About
Toyobo Co., Ltd., together with its subsidiaries, manufactures, processes, and sells various films, life sciences, environmental and functional materials, and fibers and textiles products in Japan, China, Southeast Asia, and internationally. It operates through five segments: Film; Life Science; Environmental and Functional Materials; Functional Fibers and Trading; and Real Estate. The company offers industrial films for liquid crystal polarizers, displays, synthetic paper, labels, and ceramic capacitors; and packaging films for food packaging and other products. It also provides hollow fiber membranes for artificial kidneys and food, beverage, and industrial membranes; antithrombogenic polymers, nerve regeneration guidance conduits, and bone void fillers with collagen; contract manufacturing of injections, contract packaging, and contract testing; enzymes for diagnostic reagent, reagents for life science research, and IVD devices and reagents; and cosmetics ingredients. In addition, the company offers engineering plastics and elastomer; filter materials, equipment and device systems, and bag filters; reverse osmosis membrane modules; cushion materials for seatings, mattresses, and bedclothes; recycled polyester staple fibers and polyester spunbonds; polyethylene and PBO fibers; industrial adhesives and coatings, as well as water-wash letterpress plates; and fine chemicals and pharmaceutical intermediates. Further, it is involved in the provision of industrial fibers and civil materials, comfort evaluation technology, airbag fabrics, adhesives and coating materials, and clothing fiber functional materials; and rental and management of real estate properties. The company was founded in 1882 and is headquartered in Kita, Japan.